JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 5 No. 6 428-443
© 1964 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Spar, I. L.
Right arrow Articles by Desiderio, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Spar, I. L.
Right arrow Articles by Desiderio, M. A.

Immunological Removal of Circulating I131-Labeled Rabbit Antibody to Rat Fibrinogen in Normal and Tumor-Bearing Rats1,2,

Irving L. Spar, PH.D. 3, Ruth L. Goodland, M.S. and Mary Ann Desiderio, B.S.

Rochester, New York

ABSTRACT

Purified I131 rabbit antibody to rat fibrinogen has been substantially removed from circulation using goat antiserum to rabbit gamma globulin. Subsequent studies on I131 activity in organs of such rates show considerable immediate deposition of the radioactivity in the liver and somewhat less in the spleen; this is eliminated in 6–12 hours. I131 determinations on Murphy-Sturm tumors in such immunologically treated animals demonstrate little, if any, loss of tumor-deposited I131 for the first 24 hours. The bearing of these results on scintillation scanning techniques for tumors and thrombi are discussed.

FOOTNOTES

1 Department of Radiation Biology, University of Rochester, School of Medicine and Dentistry, Rochester, New York.

2 This paper is based on work performed under contract with the United States Atomic Energy Commission at the University of Rochester Atomic Energy Project, Rochester, New York, and was also supported by U.S.P.H.S. Research Grant CA 6982.

3 Presented, in part, at the Federation of American Societies for Experimental Biology, Atlantic City, New Jersey, April, 1963.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1964 by the Society of Nuclear Medicine.